Business / Finance

RSS

Cerillo showcases wireless, scalable, off-the-shelf co-culture solution

Cerillo, a biotechnology company at the forefront of developing advanced research platforms for the study of the microbiome, will host demonstrations of the company’s new co-culture duet system at ASM Microbe 2023 from June 16-18th in Houston, Texas at booth #704.

From Cerillo 15 Jun 2023

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

From Charles Rivers Laboratories Cell and Gene Therapy 13 Jun 2023

Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘clinical trial in a dish’ for Alzheimer’s disease

Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease (AD) patient samples.

From Axol Bioscience Ltd 7 Jun 2023

INTEGRA Biosciences’ pipettes help to combat prostate cancer

The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment.

From INTEGRA Biosciences 6 Jun 2023

ESPG AG publishes annual report 2022 and looks back on successful year

ESPG AG, a real estate company specialising in science parks, today published its audited annual financial statements for 2022, which have been issued with an unqualified audit opinion by the auditor.

From The European Science Park Group (ESPG) 6 Jun 2023

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

REPROCELL today announces the launch of a new commercial service, Pharmacology-AI.

From REPROCELL 2 Jun 2023

ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033

The European Science Park Group, a real estate company specialising in science parks, has extended the lease agreement with the anchor tenant of the Science Park “Lab City” in Neu-Ulm until 31 December 2033.

From The European Science Park Group (ESPG) 2 Jun 2023

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

eMolecules acquires Specs Compound Handling B.V.

Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers.

From eMolecules 26 May 2023

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Researchers can now order their mutation of choice in bit.bio’s opti-oxTM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated into drug discovery workflows.

From bit.bio 24 May 2023

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

A collaborative agreement between Izon Science and Agarose Bead Technologies (ABT) offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

From Agarose Bead Technologies 16 May 2023

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Affordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities.

From Bruker Cellular Analysis 16 May 2023

H.E.L Group makes senior appointments as it continues to scale globally

Hasan Hallaq, PhD appointed as European Sales Director, Victoria Ordsmith joins as Director of Marketing and Sarennah Longworth-Cook promoted Director of People.

From H.E.L Group 16 May 2023

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Through a recent platform demonstration project, LabGenius’ machine learning-driven lead optimisation capability delivered dozens of novel T-cell engagers with best-in-class killing selectivity.

From LabGenius 16 May 2023

Business / Finance

Cerillo showcases wireless, scalable, off-the-shelf co-culture solution

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘clinical trial in a dish’ for Alzheimer’s disease

INTEGRA Biosciences’ pipettes help to combat prostate cancer

ESPG AG publishes annual report 2022 and looks back on successful year

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

eMolecules acquires Specs Compound Handling B.V.

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

H.E.L Group makes senior appointments as it continues to scale globally

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Vector Biolabs expands viral vector manufacturing capacity and adds to QC capabilities

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Global Access Diagnostics (GADx) welcomes new leadership

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News